Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus

European Journal of Heart Failure

Volumn 5, Issue 6, 2003, Pages 803-809

  Nodari, Savina ^a   Metra, Marco ^a   Dei Cas, Alessandra ^b   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

Author keywords

Carvedilol; Chronic heart failure; Concomitant diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLICLAZIDE; RECOMBINANT HUMAN INSULIN;

ADULT; AGED; ARTICLE; ASTHMA; BRADYCARDIA; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; LONG TERM DEPRESSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RAYNAUD PHENOMENON; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; AGED; CARBAZOLES; CHRONIC DISEASE; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROPANOLAMINES; RADIONUCLIDE VENTRICULOGRAPHY; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 1042267412     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00151-X     Document Type: Article

References (33)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. J Am Med Assoc. 241:1979;2035-2038.
2. Aronow W.S., Ahn C. Incidence of heart failure in 2737 older persons with and without diabetes mellitus. Chest. 115:1999;867-868.
3. O'Connor C.M., Hathaway W.R., Bates E.R., et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J. 133:1997;663-673.
4. Ali A.S., Rybicki B.A., Alam M., Wulbrecht N., et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 138:1999;1133-1139.
5. Shindler D.M., Kostis J.B., Yusuf S., et al. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol. 77:1996;1017-1020.
6. Solang L., Malmberg K., Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J. 20:1999;789-795.
7. Suskin N., McKelvie R.S., Burns R.J., et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 21:2000;1368-1375.
8. Philbin E.F., DiSalvo T.G. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol. 33:1999;1560-1566.
9. Krumholz H.M., Chen Y.T., Wang Y., Vaccarino V., Radford M.J., Horwitz R.I. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 139:2000;72-77.
10. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
11. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
12. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
13. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 22:2001;1527-1560.
14. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation. 104:2001;2996-3007.
15. Jacob S., Rett K., Henriksen E.J. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? Am J Hypertens. 11:1998;1258-1265.
16. Gheorghiade M., Goldstein S. Beta-blockers in the post-myocardial infarction patient. Circulation. 106:2002;394-398.
17. Jacob S., Rett K., Wicklmayr M., Agrawal B., Augustin H.J., Dietze G.J. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens. 14:1996;489-494.
18. Giugliano D., Acampora R., Marfella R., et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann Intern Med. 126:1997;955-959.
19. Refsgaard J., Thomsen C., Andreasen F., Gotzsche O. Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure. Eur J Heart Fail. 4:2002;445.
20. Malmberg K., Ryden L., Hamsten A., et al. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res. 34:1997;248-253.
21. Malmberg K., Herlitz J., Hjalmarson A., Ryden L. Effects of metoprolol on mortality and late reinfarction in diabetics with suspected acute myocardial infarction: retrospective data from two large studies. Eur Heart J. 10:1989;423-428.
22. Kjekshus J., Gilpin E., Cali G., et al. Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J. 11:1990;43-50.
23. Gottlieb S.S., McCarter R.J., Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 339:1998;489-497.
24. Chen J., Marciniak T.A., Radford M.J., et al. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly patients: results from the national cooperative cardiovascular project. J Am Coll Cardiol. 34:1999;1388-1394.
25. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Effect of carvedilol on LV function and mortality in diabetic vs. non-diabetic patients with ischemic or non-ischemic cardiomyopathy. Circulation. 94:1996;I-664. abstract.
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998;21(Suppl 1):S5-19.
27. Metra M., Giubbini R., Nodari S., Boldi E., Modena M.G., Dei Cas L. Differential effects of (β-blockers in patients with heart failure. A prospective, double-blind comparison of the long-term effects of metoprolol vs. carvedilol. Circulation. 102:2000;546-551.
28. Metra M., Faggiano P., D'Aloia A., et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol. 33:1999;943-950.
29. Wasserman K., Hansen J.E., Sue D.Y., Whipp B.J., Casaburi R. Normal values. Wasserman K., Hansen J.E., Sue D.Y., Whipp B.J., Casaburi R. Principles of exercise testing and interpretation. 2nd ed:1994;112-131 Lea and Febiger, Philadelphia.
30. Erdmann E., Lechat P., Verkenne P., Wiemann H. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail. 3:2001;469-479.
31. Deedwania PC, Giles TD, Ghali JK, Gottlieb SS. Safety and efficacy of treatment with metoprolol CR/XL in diabetic patients with heart failure. Circulation 2000; 102(Suppl II): II-779 (abstract).
32. Mohacsi P, Fowler MB, Krum H et al. Should physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study. Circulation 2001;104(Suppl II):II-754 (abstract).
33. Krum H., Ninio D., MacDonald P. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart. 84:2000;615-619.